Doliver Capital Advisors »

Miragen Therapeutics shares owned by Doliver Capital Advisors

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Doliver Capital Advisors from 13F filings

Historical chart of Doliver Capital Advisors investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Doliver Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Doliver Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $551k 30k 18.37

More positions owned by Doliver Capital Advisors

Exxon Mobil Corporation (XOM)
Ishares Tr Core S&p Us Gwt (IUSG)
Tidal Trust Ii Dga Co Pl Ab Etf (HF)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Eaton Corp SHS (ETN)
Meta Platforms Cl A (META)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Russell 2000 Etf (IWM)
Micron Technology (MU)
Enterprise Products Partners (EPD)

View all positions for Doliver Capital Advisors

Top funds holding Miragen Therapeutics

FMR
BlackRock
Bellevue Group
State Street Corporation
Vanguard Capital Management
Fairmount Funds Management
VR Adviser
Paradigm Biocapital Advisors
Wellington Management Company
Citadel Advisors
Kynam Capital Management
Geode Capital Management
Balyasny Asset Management
Novo A/S
Baker Bros. Advisors

View all funds holding Miragen Therapeutics